Small Businesses in Non-addictive Analgesic Therapeutics Development: HEAL Initiative Webinar on funding opportunities beyond SBIR/STTR

This webinar is for Small Businesses to learn about additional funding mechanisms beyond SBIR to support the discovery and pre-clinical development of non-addictive pain treatments:

HEAL Initiative: Planning Studies for Initial Analgesic Development (R61 Clinical Trial Not Allowed) RFA-NS-21-029

HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development (U19, Clinical Trial Not Allowed) RFA-NS-21-015

HEAL Initiative: Non-addictive Analgesic Therapeutics [Small Molecules and Biologics] Development to Treat Pain (UG3/UH3 Clinical Trial Optional) RFA-NS-21-010

The goal of these announcements is to accelerate the optimization and development of promising small molecule and biologic hits/leads to Phase I clinical trials and readiness for the Early Phase Pain Investigation Clinical Network (EPPIC-Net) or other Phase II clinical studies.

View the Webinar Recording

HEAL Initiative Webinar on Non-addictive Analgesic Therapeutics Development

November 8, 2021, 4 p.m. Eastern Time (U.S. and Canada)

• Moderated by Emily Caporello, Ph.D., Director, NINDS Small Business Program
• Presentations by:
  • Michael L. Oshinsky, Ph.D. Program Director, HEAL/NINDS
  • Julia L. Bachman, Ph.D., Scientific Project Manager, HEAL/NINDS
  • Mary Ann Pelleymounter, Ph.D Program Director, HEAL/NINDS
• Live Q&A to follow                                    

Questions can also be submitted prior to the event to [email protected]